Literature DB >> 913002

Clinical pharmacokinetics of hydrallazine.

T Talseth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 913002     DOI： 10.2165/00003088-197702050-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  52 in total

1.  Elimination rate of N-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in man.

Authors:  C Graffner
Journal:  J Pharmacokinet Biopharm       Date:  1975-04

2.  Studies of human patterns of isoniazid metabolism using an intravenous fall-off technique with a chemical method.

Authors:  J W JENNE
Journal:  Am Rev Respir Dis       Date:  1960-01

3.  Pharmacological properties of hydrallazine, dihydrallazine and some related compounds.

Authors:  S M KIRPEKAR; J J LEWIS
Journal:  J Pharm Pharmacol       Date:  1957-12       Impact factor: 3.765

4.  Studies on hydralazine; evidence for a peripheral site of action.

Authors:  A STUNKARD; L WERTHEIMER; W REDISCH
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

5.  Rheumatic and febrile syndrome during prolonged hydralazine treatment.

Authors:  H P DUSTAN; R D TAYLOR; A C CORCORAN
Journal:  J Am Med Assoc       Date:  1954-01-02

6.  Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects.

Authors:  J D MORROW; H A SCHROEDER; H M PERRY
Journal:  Circulation       Date:  1953-12       Impact factor: 29.690

7.  Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension.

Authors:  J H MOYER
Journal:  AMA Arch Intern Med       Date:  1953-04

8.  Studies on the control of hypertension by hyphex. IV. Levels of the agents in urine and blood.

Authors:  H M PERRY; H A SCHROEDER; J D MORROW
Journal:  Am J Med Sci       Date:  1954-10       Impact factor: 2.378

9.  Metabolism and disposition of hydralazine-14C in man and dog.

Authors:  J M Lesser; Z H Israili; D C Davis; P G Dayton
Journal:  Drug Metab Dispos       Date:  1974 Jul-Aug       Impact factor: 3.922

10.  The determination of hydralazine in plasma by gas-liquid chromatography.

Authors:  D B Jack; S Brechbüher; P H Degen; P Zbinden; W Riess
Journal:  J Chromatogr       Date:  1975-12-10
View more
  15 in total

Review 1.  Drug kinetics and hepatic blood flow.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

Review 2.  Hepatic first-pass metabolism in liver disease.

Authors:  T F Blaschke; P C Rubin
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

3.  Three times daily or 8-hourly.

Authors:  R Nigam; B J Loveday; S L Grainger; D G Maxton
Journal:  J R Soc Med       Date:  1986-01       Impact factor: 5.344

Review 4.  Pharmacologic treatment of chronic pediatric hypertension.

Authors:  Renee F Robinson; Milap C Nahata; Donald L Batisky; John D Mahan
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  Hydralazine-induced peripheral neuropathy seen in a Japanese slow acetylator patient.

Authors:  G Tsujimoto; Y Horai; T Ishizaki; K Itoh
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

6.  Clinical pharmacological studies with the vasodilator endralazine in patients with renal impairment.

Authors:  H L Elliott; P A Meredith; L Sloan; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of hydralazine.

Authors:  T M Ludden; J L McNay; A M Shepherd; M S Lin
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

8.  Dosage adjustment in renal insufficiency.

Authors:  G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

9.  Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

Authors:  B Hallengren; O R Nilsson; B E Karlberg; A Melander; L Tegler; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.